Research coverage
Classification review pending
- Price Chart
- Available
- Reported Cash
- Available
- Pipeline
- Scanned — no results
- Catalysts
- Available
Reported cash
Cash and cash equivalents · Restricted cash and marketable securities excluded
Cash verified Nov 16, 2026
Price chart
What changed?
No verified development in tracked sources.
Upcoming catalysts
Next verified event · FDA target date
lonvo-z · March 10, 2027
Announced Nov 5, 2026
Official announcementSource wording
In September, the U.S. Food and Drug Administration (FDA) accepted the Biologics License Application (BLA) for lonvo-z and granted the BLA Priority Review with a Prescription Drug User Fee Act (PDUFA) target action date of March 10, 2027. Additionally, FDA advised that it is not
Drug pipeline
0 programs · 0 verified studies
Scanned — no results
10 unverified sponsor matches remain unlinked.
Verified timeline
0 recordsNo verified developments in tracked sources.